Wednesday, an analyst from H.C. Wainwright increased the price target for Tyra Biosciences (NASDAQ:TYRA) to $23 from $19, maintaining a Buy rating on the stock. The adjustment reflects the firm's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results